A potential link of oxidative stress and cell cycle regulation for development of endometriosis

Gynecological Endocrinology

Volumn 28, Issue 11, 2012, Pages 897-902

  Shigetomi, Hiroshi ^a   Higashiura, Yumi ^a   Kajihara, Hirotaka ^a   Kobayashi, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell cycle checkpoints; Endometriosis; Iron; Oxidative stress

Indexed keywords

CYCLOOXYGENASE 2; FORKHEAD TRANSCRIPTION FACTOR; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; INTERLEUKIN 8; MICRORNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE REGULATION; CELL DAMAGE; CELL MIGRATION; CELL PROLIFERATION; CELL RESPIRATION; CELL SURVIVAL; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DNA METHYLATION; DNA REPAIR; DNA STRAND BREAKAGE; DNA SYNTHESIS; DOWN REGULATION; ENDOMETRIOSIS; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; IRON OVERLOAD; MENSTRUATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RNA DEGRADATION;

ANIMALS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL PROLIFERATION; DNA DAMAGE; DNA-BINDING PROTEINS; ENDOMETRIOSIS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; INFLAMMATION; IRON; MICRORNAS; OXIDATIVE STRESS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84867536652     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.683071     Document Type: Article

References (62)

1. Sayasneh A, Tsivos D, Crawford R. Endometriosis and ovarian cancer: A systematic review. ISRN Obstet Gynecol 2011;2011:140310.
2. Yamaguchi K, Mandai M, Toyokuni S, Hamanishi J, Higuchi T, Takakura K, Fujii S. Contents of endometriotic cysts, especially the high concentration of free iron, are a possible cause of carcinogenesis in the cysts through the iron-induced persistent oxidative stress. Clin Cancer Res 2008;14:32-40.
3. Matsuzaki S, Canis M, Vaurs-Barrie C, Pouly JL, Boespflug-Tanguy O, Penault-Llorca F, Dechelotte P, et al. DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. Mol Hum Reprod 2004;10:719-728.
4. Calcagno A, Grassi T, Mariuzzi L, Marzinotto S, Londero AP, Orsaria M, Beltrami CA, Marchesoni D. Expression patterns of Aurora A and B kinases, Ki-67 and the estrogen and progesterone receptors determined using an endometriosis tissue microarray model. Hum Reprod 2011;26:2731-2741.
5. Bulun SE, Cheng YH, Pavone ME, Xue Q, Attar E, Trukhacheva E, Tokunaga H, et al. Estrogen receptor-β, estrogen receptor-α, and progesterone resistance in endometriosis. Semin Reprod Med 2010;28:36-43.
6. Borghese B, Barbaux S, Mondon F, Santulli P, Pierre G, Vinci G, Chapron C, Vaiman D. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation. Mol Endocrinol 2010;24:1872-1885.
7. Kajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, et al. New insights into the pathophysiology of endometriosis: From chronic inflammation to danger signal. Gynecol Endocrinol 2011;27:73-79.
8. Yamada Y, Shigetomi H, Onogi A, Haruta S, Kawaguchi R, Yoshida S, Furukawa N, et al. New insights into pattern recognition receptors and their ligands in gynecologic pathologies. Hum Immunol 2011;72:213-218.
9. Kawano Y, Nasu K, Li H, Tsuno A, Abe W, Takai N, Narahara H. Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod 2011;26:2486-2498.
10. Zhao H, Traganos F, Albino AP, Darzynkiewicz Z. Oxidative stress induces cell cycle-dependent Mre11 recruitment, ATM and Chk2 activation and histone H2AX phosphorylation. Cell Cycle 2008;7:1490-1495.
11. Yamada Y, Shigetomi H, Onogi A, Haruta S, Kawaguchi R, Yoshida S, Furukawa N, et al. Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer 2011;21:1200-1207.
12. Hirota Y, Osuga Y, Hirata T, Harada M, Morimoto C, Yoshino O, Koga K, et al. Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells. Hum Reprod 2005;20:3547-3553.
13. Krikun G, Schatz F, Taylor H, Lockwood CJ. Endometriosis and tissue factor. Ann N Y Acad Sci 2008;1127:101-105.
14. Hirota Y, Osuga Y, Hirata T, Yoshino O, Koga K, Harada M, Morimoto C, et al. Possible involvement of thrombin/protease-activated receptor 1 system in the pathogenesis of endometriosis. J Clin Endocrinol Metab 2005;90:3673-3679.
15. Dzmann S, Gessler F, Harter PN, Gerlach R, Mittelbronn M, Seifert V, Kel D. The pro-migratory and pro-invasive role of the procoagulant tissue factor in malignant gliomas. Cell Adh Migr 2010;4:515-522.
16. Chu AJ. Tissue factor, blood coagulation, and beyond: An overview. Int J Inflam 2011;2011:367284.
17. Schaffner F, Versteeg HH, Schillert A, Yokota N, Petersen LC, Mueller BM, Ruf W. Cooperation of tissue factor cytoplasmic domain and PAR2 signaling in breast cancer development. Blood 2010;116:6106-6113.
18. Van Langendonckt A, Casanas-Roux F, Donnez J. Iron overload in the peritoneal cavity of women with pelvic endometriosis. Fertil Steril 2002;78:712-718.
19. Evstatiev R, Gasche C. Iron sensing and signalling. Gut 2011.
20. Yu Y, Kovacevic Z, Richardson DR. Tuning cell cycle regulation with an iron key. Cell Cycle 2007;6:1982-1994.
21. PrD, Franke SI, Henriques JA, Fenech M. Iron and genome stability: An update. Mutat Res 2012.
22. Kobayashi H, Kajihara H, Yamada Y, Tanase Y, Kanayama S, Furukawa N, Noguchi T, et al. Risk of carcinoma in women with ovarian endometrioma. Front Biosci (Elite Ed) 2011;3:529-539.
23. Brookes MJ, Boult J, Roberts K, Cooper BT, Hotchin NA, Matthews G, Iqbal T, Tselepis C. A role for iron in Wnt signalling. Oncogene 2008;27:966-975.
24. Steegmann-Olmedillas JL. The role of iron in tumour cell proliferation. Clin Transl Oncol 2011;13:71-76.
25. Kong SL, Li G, Loh SL, Sung WK, Liu ET. Cellular reprogramming by the conjoint action of ERa, FOXA1, and GATA3 to a ligand-inducible growth state. Mol Syst Biol 2011;7:526.
26. Makker A, Goel MM, Das V, Agarwal A. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: An update. Gynecol Endocrinol 2012;28:175-181.
27. Attar E, Bulun SE. Aromatase and other steroidogenic genes in endometriosis: Translational aspects. Hum Reprod Update 2006;12:49-56.
28. Wu MH, Lu CW, Chuang PC, Tsai SJ. Prostaglandin E2: The master of endometriosis? Exp Biol Med (Maywood) 2010;235:668-677.
29. Sacco K, Portelli M, Pollacco J, Schembri-Wismayer P, Calleja-Agius J. The role of prostaglandin E2 in endometriosis. Gynecol Endocrinol 2012;28:134-138.
30. Lee J, Banu SK, Rodriguez R, Starzinski-Powitz A, Arosh JA. Selective blockade of prostaglandin E2 receptors EP2 and EP4 signaling inhibits proliferation of human endometriotic epithelial cells and stromal cells through distinct cell cycle arrest. Fertil Steril 2010;93:2498-2506.
31. Bulun SE, Zeitoun KM, Takayama K, Sasano H. Estrogen biosynthesis in endometriosis: Molecular basis and clinical relevance. J Mol Endocrinol 2000;25:35-42.
32. Tremblay Y, Ringler GE, Morel Y, Mohandas TK, Labrie F, Strauss JF 3rd, Miller WL. Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cen - q25. J Biol Chem 1989;264:20458-20462.
33. Kajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, et al. Clear cell carcinoma of the ovary: Potential pathogenic mechanisms (Review). Oncol Rep 2010;23:1193-1203.
34. Matsuzaki S, Schubert B. Oxidative stress status in normal ovarian cortex surrounding ovarian endometriosis. Fertil Steril 2010;93:2431-2432.
35. Xu B, Hamada S, Kusuki I, Itoh R, Kitawaki J. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis. Gynecol Oncol 2011;120:239-246.
36. van den Heuvel S. Cell-cycle regulation. WormBook 2005:1-16.
37. Hitomi M, Stacey DW. The checkpoint kinase ATM protects against stress-induced elevation of cyclin D1 and potential cell death in neurons. Cytometry A 2010;77:524-533.
38. Castillo P, Bogliolo M, Surralles J. Coordinated action of the Fanconi anemia and ataxia telangiectasia pathways in response to oxidative damage. DNA Repair (Amst) 2011;10:518-525.
39. Semlitsch M, Shackelford RE, Zirkl S, Sattler W, Malle E. ATM protects against oxidative stress induced by oxidized low-density lipoprotein. DNA Repair (Amst) 2011;10:848-860.
40. Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci USA 2010;107:4153-4158.
41. Zhan H, Suzuki T, Aizawa K, Miyagawa K, Nagai R. Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence. J Biol Chem 2010;285:29662-29670.
42. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science 2010;330:517-521.
43. Yalcin S, Zhang X, Luciano JP, Mungamuri SK, Marinkovic D, Vercherat C, Sarkar A, et al. Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem 2008;283:25692-25705.
44. Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1β (HNF-1β) in clear cell tumors and endometriosis of the ovary. Mod Pathol 2006;19:83-89.
45. Kobayashi H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, et al. The role of hepatocyte nuclear factor-1β in the pathogenesis of clear cell carcinoma of the ovary. Int J Gynecol Cancer 2009;19:471-479.
46. Ronnebaum SM, Patterson C. The FoxO family in cardiac function and dysfunction. Annu Rev Physiol 2010;72:81-94.
47. Tsai WB, Chung YM, Takahashi Y, Xu Z, Hu MC. Functional interaction between FOXO3a and ATM regulates DNA damage response. Nat Cell Biol 2008;10:460-467.
48. de Keizer PL, Burgering BM, Dansen TB. Forkhead box o as a sensor, mediator, and regulator of redox signaling. Antioxid Redox Signal 2011;14:1093-1106.
49. Fu L, Girling JE, Rogers PA. Expression of Fox head protein 1 in human eutopic endometrium and endometriosis. Reprod Sci 2008;15:243-252.
50. Klagge A, Weidinger C, Krause K, Jessnitzer B, Gutknecht M, Fuhrer D. The role of FOXO3 in DNA damage response in thyrocytes. Endocr Relat Cancer 2011;18:555-564.
51. Christian M, Lam EW, Wilson MS, Brosens JJ. FOXO transcription factors and their role in disorders of the female reproductive tract. Curr Drug Targets 2011;12:1291-1302.
52. Shazand K, Baban S, PrivC, Malette B, Croteau P, LagacM, Racine JB, Hugo P. FOXO1 and c-jun transcription factors mRNA are modulated in endometriosis. Mol Hum Reprod 2004;10:871-877.
53. AndrGM, Barbosa CP, Teles JS, Vilarino FL, Christofolini DM, Bianco B. Analysis of FOXP3 polymorphisms in infertile women with and without endometriosis. Fertil Steril 2011;95:2223-2227.
54. Bueno MJ, Pez de Castro I, Malumbres M. Control of cell proliferation pathways by microRNAs. Cell Cycle 2008;7:3143-3148.
55. Teague EM, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update 2010;16:142-165.
56. Dai L, Gu L, Di W. MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKK{β}/NF-kB pathway and reduced interleukin-8 expression. Mol Hum Reprod. 2012;18:136-145.
57. Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, Matzuk MM. Functional microRNA involved in endometriosis. Mol Endocrinol 2011;25:821-832.
58. Petracco R, Grechukhina O, Popkhadze S, Massasa E, Zhou Y, Taylor HS. MicroRNA 135 regulates HOXA10 expression in endometriosis. J Clin Endocrinol Metab 2011;96:E1925-E1933.
59. Aghajanova L, Giudice LC. Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod Sci 2011;18:229-251.
60. Lam EW, Shah K, Brosens J. The role of microRNAs and FOXO transcription factors in cycling endometrium and cancer. J Endocrinol. 2012;212:13-25.
61. Teague EM, Print CG, Hull ML. The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update. 2010;16:142-165.
62. Flores I, Rivera E, Ruiz LA, Santiago OI, Vernon MW, Appleyard CB. Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. Fertil Steril 2007;87:1180-1199.